Search Tag: biomarker
2024 13 Jun
A new study published in Microbiology Spectrum reveals that the nasal microbiota of ICU patients can effectively distinguish between sepsis and non-sepsis cases, outperforming gut microbiota in predicting sepsis. These findings have implications for developing diagnostic strategies and advancing critical care medicine. Historically, the focus...Read more
2024 17 May
In locally advanced pancreatic cancer (LAPC), preventing local progression is crucial as it significantly impacts survival rates. Intraoperative radiotherapy (IORT) has shown promise in improving local disease control rates. However, determining the risk of progression in patients initially assessed as stable disease (SD) after IORT remains challenging....Read more
2023 01 Feb
In-vitro diagnostic tests allow for quick results and prompt decision-making by medical professionals in near-patient settings. The abioSCOPE® device uses nanofluidic technology to quickly measure the number of molecules in a sample using a small amount of fluid and minimal preparation, resulting in fast results. Pancreatic stone protein (PSP) is a...Read more
2021 20 Apr
Sepsis is a global healthcare problem, with 50 million cases each year and 11 million related deaths 1 . It’s the life-threatening complication of an infection, in which the host’s immune response to a pathogen damages its own organs. The clinical diagnosis of sepsis relies mostly on signs and symptoms that are neither sensitive nor specific enough...Read more
2020 29 Aug
Prof. Carlo Tascini is Head of Infectious Diseases Clinic at Udine University Hospital. Prior to that, he was the Head of First Division of Infectious Diseases Unit at Cotugno Hospital. His field of interests include endocarditis, meningitis, sepsis, MDR bacterial infection and fungal infections. HealthManagement.org spoke to Prof. Tascini about...Read more
2019 30 Aug
The controversy surrounding the efficacy of the blood infection biomarker, procalcitonin (PCT), for guidance in acute infections and sepsis treatment remains. PCT is a calcitonin precursor produced by epithelial cells when infected with bacteria and has been identified as a marker due to the protein levels’ variation upon infection initiation and cessation....Read more
2019 26 Aug
Summary: Combine the characteristic of our engagement with social media with existing technology and how we could improve patient compliance in the not so distant future. Patient treatment compliance is a significant barrier and a challenge for healthcare professionals the world over. While several studies have been conducted leading to...Read more
2018 03 May
Masimo has announced the use of Masimo technologies – O3® regional oximetry and SedLine® brain function monitoring – in two abstracts presented at the 2018 Annual Meeting of the International Anesthesia Research Society(IARS). Both studies investigated links between postoperative delirium and particular biomarkers. In the first study 1 , Dr. Aymen...Read more
2017 27 Jun
Sepsis most often presents to the emergency department (ED), and delayed detection is harmful. The white blood count (WBC) is often used to detect sepsis in the ED. New research shows that volume increases of circulating immune cells, or monocytes, adds value to the WBC for early sepsis detection in the ED. "This study shows that the monocyte distribution...Read more
2017 19 Jun
Royal Philips , a global leader in health technology, has announced the launch of its Xplore i web - based informatics platform for drug research and biomarker discovery. Part of Philips’ computational pathology portfolio, t he new release marks a major upgrade for both pharma and academic researchers,...Read more
2017 12 May
A new microRNA biomarker has been identified that may have a strong association with the incidence of atrial fibrillation. The findings were presented today at Heart Rhythm 2017, the Heart Rhythms Society's 38th Annual Scientific Sessions in Chicago. See Also : New Source of Electrical Instability in the Heart Researchers from Intermountain...Read more
2016 04 Jul
A combination of imaging and mathematics can help identify if aggressive treatment is needed when a woman has been diagnosed with early stage breast cancer. The new technology – biomarker ratio imaging microscopy, or BRIM – can identify aggressive forms of ductal carcinoma in situ (DCIS), or stage 0 breast cancer, from non-aggressive varieties,...Read more